Ochsner Community Clinical Oncology Program

Ochsner 社区临床肿瘤学计划

基本信息

批准号：
6925726
负责人：
CARL G KARDINAL
金额：
$ 36.85万
依托单位：
OCHSNER CLINIC FOUNDATION
依托单位国家：
美国
项目类别：
财政年份：
1983
资助国家：
美国
起止时间：
1983-09-01 至 2010-05-31
项目状态：
已结题

项目摘要

DESCRIPTION (provided by applicant): The Ochsner CCOP's global aim for the next five years is to provide the unique population we serve in South Louisiana and Mississippi the opportunity to participate in state-of-the-art cancer therapy available only through clinical trials. This culturally rich rural and urban racially mixed patient base has benefited greatly from CCOP participation, with >3500 subjects entered on NCI approved clinical trials since 1983. Other specific aims are: 1} to diversify patients/participants enrolled on clinical trials by adding two largely rural affiliates in Covington and Hammond, Louisiana. 2) To embrace pediatric oncology as a major focus to broaden the CCOP patient base. 3) To establish strong relationships with the 25 Ochsner Satellite Clinics to create a large patient base of potential subjects for Cancer Control. 4) To partner medical oncology with other medical specialists to encourage an exchange of information that will generate enthusiasm for referring patients for clinical trials. 5) To monitor closely the underserved patients/participants to ensure that financial and social barriers are addressed to facilitate their enrollment in clinical trials. 6) To present continuing education programs to community physicians encompassing the latest results from clinical trials to encourage rapid dissemination of knowledge that leads to practice changes positively impacting the cancer patient. 7) To hold interdisciplinary monthly protocol meetings to rigorously review protocols for determining investigators interest and commitment. 8) To utilize to the fullest extent the skills of the highly motivated cancer control coordinator recruited in 2004. 9) To make a priority the training and development of the Co-Pi to assure continuity. 10) To make participation in correlative studies an integral responsibility for investigators enrolling patients on study.

描述（由申请人提供）： Ochsner CCOP 未来五年的全球目标是为我们在南路易斯安那州和密西西比州服务的独特人群提供参与仅通过临床试验才能获得的最先进癌症治疗的机会。这个文化丰富的农村和城市种族混合患者群体从 CCOP 参与中受益匪浅，自 1983 年以来已有超过 3500 名受试者参加了 NCI 批准的临床试验。其他具体目标是： 1} 通过增加两个主要参与者，使参加临床试验的患者/参与者多样化路易斯安那州卡温顿和哈蒙德的农村分支机构。 2) 将儿科肿瘤学作为扩大 CCOP 患者基础的主要焦点。 3) 与 25 个 Ochsner 卫星诊所建立牢固的关系，为癌症控制的潜在受试者建立庞大的患者基础。 4) 肿瘤内科与其他医学专家合作，鼓励信息交流，从而激发转诊患者参加临床试验的热情。 5) 密切监测服务不足的患者/参与者，以确保解决经济和社会障碍，以促进他们参加临床试验。 6) 向社区医生提供继续教育计划，其中包括临床试验的最新结果，以鼓励知识的快速传播，从而导致实践改变，对癌症患者产生积极影响。 7) 每月举行跨学科方案会议，严格审查方案以确定研究者的兴趣和承诺。 8) 充分利用 2004 年招募的积极主动的癌症控制协调员的技能。 9) 优先考虑 Co-Pi 的培训和发展，以确保连续性。 10) 使参与相关研究成为研究者招募患者的不可分割的责任。